Matches in Wikidata for { <http://www.wikidata.org/entity/Q38045763> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q38045763 description "article científic" @default.
- Q38045763 description "article scientifique" @default.
- Q38045763 description "articol științific" @default.
- Q38045763 description "articolo scientifico" @default.
- Q38045763 description "artigo científico" @default.
- Q38045763 description "artigo científico" @default.
- Q38045763 description "artigo científico" @default.
- Q38045763 description "artikel ilmiah" @default.
- Q38045763 description "artikull shkencor" @default.
- Q38045763 description "artículo científico" @default.
- Q38045763 description "artículu científicu espublizáu en 2012" @default.
- Q38045763 description "bilimsel makale" @default.
- Q38045763 description "scienca artikolo" @default.
- Q38045763 description "scientific article published on 21 September 2012" @default.
- Q38045763 description "scientific article published on 21 September 2012" @default.
- Q38045763 description "scientific article published on 21 September 2012" @default.
- Q38045763 description "vedecký článok" @default.
- Q38045763 description "vetenskaplig artikel" @default.
- Q38045763 description "videnskabelig artikel" @default.
- Q38045763 description "vitenskapelig artikkel" @default.
- Q38045763 description "vitskapeleg artikkel" @default.
- Q38045763 description "vědecký článek" @default.
- Q38045763 description "wetenschappelijk artikel" @default.
- Q38045763 description "wissenschaftlicher Artikel" @default.
- Q38045763 description "наукова стаття, опублікована у вересні 2012" @default.
- Q38045763 description "научная статья" @default.
- Q38045763 description "научни чланак" @default.
- Q38045763 description "מאמר מדעי" @default.
- Q38045763 description "مقالة علمية نشرت في 21 سبتمبر 2012" @default.
- Q38045763 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38045763 name "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 name "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 name "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 type Item @default.
- Q38045763 label "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 label "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 label "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 prefLabel "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 prefLabel "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 prefLabel "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 P1433 Q38045763-5188950D-CE6E-4488-8F09-60A131CDB4B1 @default.
- Q38045763 P1476 Q38045763-0FF09B86-74A1-434A-A867-DEE4DDAB6978 @default.
- Q38045763 P2093 Q38045763-3FCE4A4D-C293-459E-AA7E-74A309C94EDC @default.
- Q38045763 P2093 Q38045763-62BF3893-07E4-483B-94D6-E349C6A3754E @default.
- Q38045763 P2093 Q38045763-89AA1E5A-4171-41C0-8D36-594D93ACDDA8 @default.
- Q38045763 P2093 Q38045763-97C14813-21E1-4370-B7FB-639263B9EB78 @default.
- Q38045763 P2093 Q38045763-BB1A4056-8F90-45EE-A62D-DC74C129BACC @default.
- Q38045763 P2093 Q38045763-F65D1313-95AA-42E4-86DC-9D18E6D37971 @default.
- Q38045763 P304 Q38045763-8DFAC8C8-F79F-42FF-B5F8-8277499F8F77 @default.
- Q38045763 P31 Q38045763-8C0CCBB1-CC67-48A2-A667-D7AF01B7DE98 @default.
- Q38045763 P356 Q38045763-C794FE51-39AF-4ED4-9CA2-36F67D535041 @default.
- Q38045763 P407 Q38045763-713FFFBE-D8DD-47CE-A664-C4037E4B6C69 @default.
- Q38045763 P433 Q38045763-0243BA25-D429-482D-9B41-612FCC1E503C @default.
- Q38045763 P478 Q38045763-CD63D352-2EE9-4387-B485-D3E8E06EE910 @default.
- Q38045763 P577 Q38045763-6BB8B2AD-7149-4D4F-8F8D-4F4AC7DE5B41 @default.
- Q38045763 P698 Q38045763-11B5321A-35EB-46AF-B323-5FAB6ACEB255 @default.
- Q38045763 P356 BJOPHTHALMOL-2012-302167 @default.
- Q38045763 P698 23001255 @default.
- Q38045763 P1433 Q13443571 @default.
- Q38045763 P1476 "Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration" @default.
- Q38045763 P2093 "Andrew C Browning" @default.
- Q38045763 P2093 "Evripidis Sykakis" @default.
- Q38045763 P2093 "Kinnar Merchant" @default.
- Q38045763 P2093 "Rajen Gupta" @default.
- Q38045763 P2093 "S James Talks" @default.
- Q38045763 P2093 "Sreekumari Pushpoth" @default.
- Q38045763 P304 "1469-1473" @default.
- Q38045763 P31 Q13442814 @default.
- Q38045763 P356 "10.1136/BJOPHTHALMOL-2012-302167" @default.
- Q38045763 P407 Q1860 @default.
- Q38045763 P433 "12" @default.
- Q38045763 P478 "96" @default.
- Q38045763 P577 "2012-09-21T00:00:00Z" @default.
- Q38045763 P698 "23001255" @default.